UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.09 +0.09 (+0.11%) GOLD FUTURES
2,331.70 +20.70 (+0.90%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,227.34 -2,049.28 (-4.24%)
Excelsior Biopharma Inc. (6496.TWO)
Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
At close: 12:48PM CST
Currency in TWD
Valuation measures4
| Market cap (intra-day) | 1.31B |
| Enterprise value | 1.10B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.73 |
| Price/book (mrq) | 1.19 |
| Enterprise value/revenue | 1.43 |
| Enterprise value/EBITDA | -37.48 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.34 |
| 52-week change 3 | -16.82% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 36.30 |
| 52-week low 3 | 27.00 |
| 50-day moving average 3 | 28.30 |
| 200-day moving average 3 | 28.64 |
Share statistics
| Avg vol (3-month) 3 | 18k |
| Avg vol (10-day) 3 | 12.6k |
| Shares outstanding 5 | 46.99M |
| Implied shares outstanding 6 | 46.99M |
| Float 8 | N/A |
| % held by insiders 1 | 59.53% |
| % held by institutions 1 | 1.79% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 6.35 |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 13 Jul 2021 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -11.80% |
| Operating margin (ttm) | 2.49% |
Management effectiveness
| Return on assets (ttm) | -3.08% |
| Return on equity (ttm) | -7.87% |
Income statement
| Revenue (ttm) | 771.56M |
| Revenue per share (ttm) | 16.80 |
| Quarterly revenue growth (yoy) | 25.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -69.31M |
| Net income avi to common (ttm) | -91.01M |
| Diluted EPS (ttm) | -1.98 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 589.92M |
| Total cash per share (mrq) | 12.56 |
| Total debt (mrq) | 354.22M |
| Total debt/equity (mrq) | 32.07% |
| Current ratio (mrq) | 5.92 |
| Book value per share (mrq) | 23.51 |
Cash flow statement
| Operating cash flow (ttm) | -134.75M |
| Levered free cash flow (ttm) | -139.51M |
© 2024 Yahoo. All rights reserved.